Log In
Print this Print this

PIM447 (formerly LGH447)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral pan-PIM kinase inhibitor
Molecular Target Pim-1 (PIM1) ; Pim-2 (PIM2)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today